(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ANNOVIANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ANNOVIANT

ST13

US500000090668127

Class

5, 10

Filing

90668127

Registration

7374872

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

04/30/2024

Trademark type

Word

Nice classes

5, 10

Filing date

04/23/2021

Registration date

04/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/30/2024

Last transaction

04/30/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-00-00

First use in commerce

2022-00-00

Drawing code

4

Owner type

16

Owner location

Alpharetta, GA

Examiner

KOVALSKY, LAURA G

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Annoviant, LLC

Representatives

Sona Dalal Sona Dalal

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Media for use in the augmentation of bone and tissue for medical purposes; Biological preparations for the treatment of cardiovascularcardiopulmonarymusculoskeletaldiseases and disordersdermatological related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascularcardiopulmonarymusculoskeletaldiseases and disordersdermatological related diseases and disorders; Pharmaceutical preparations and substances for the treatment and repairreinforcement or buttressing of soft tissue and damaged skin; Pharmaceutical preparations for wounds; Pharmaceutical preparations and substances for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Surgical tissuessurgical implants comprising artificial material; Surgical implants comprising living tissue; Biological tissue made of or by living organic bone cellsskin cellsstem cellsepithelial cellsfat cellsnerve cellsmuscle cellsconnective tissue cells intended for subsequent implantation; Biological implantsa vital processed human or animal connective tissue; Biological tissue grafts; Vascular grafts; Medical adhesives for binding internal tissue

Class 10

Artificial skin for surgical purposes; Synthetic media for use in the augmentation of bone and tissue for medical purposes; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Medical devices and apparatussurgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgeryrepairreinforcement or buttressing of soft tissueparts and fittings therefor; Surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies

Publications

History of USPTO decisions and trademark events.

41 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/30/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/26/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/24/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/09/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/09/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/17/2024

IUAF

USE AMENDMENT FILED

02/16/2024

EISU

TEAS STATEMENT OF USE RECEIVED

02/16/2024

EX3G

SOU EXTENSION 3 GRANTED

02/16/2024

EXT3

SOU EXTENSION 3 FILED

02/16/2024

EEXT

SOU TEAS EXTENSION RECEIVED

02/16/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/27/2023

EX2G

SOU EXTENSION 2 GRANTED

07/25/2023

EXT2

SOU EXTENSION 2 FILED

07/25/2023

EEXT

SOU TEAS EXTENSION RECEIVED

07/25/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/25/2023

EX1G

SOU EXTENSION 1 GRANTED

01/23/2023

EXT1

SOU EXTENSION 1 FILED

01/23/2023

EEXT

SOU TEAS EXTENSION RECEIVED

01/23/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/16/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/21/2022

PUBO

PUBLISHED FOR OPPOSITION

06/21/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/01/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/18/2022

ALIE

ASSIGNED TO LIE

05/17/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/11/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/11/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

05/11/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/11/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

05/11/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/02/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/02/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/20/2021

GNRT

NON-FINAL ACTION E-MAILED

12/20/2021

CNRT

NON-FINAL ACTION WRITTEN

12/20/2021

DOCK

ASSIGNED TO EXAMINER

12/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2021

NWAP

NEW APPLICATION ENTERED

04/27/2021

Continuous trademark protection

Get notified about every new filing that threatens ANNOVIANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.